MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) Files An 8-K Regulation FD Disclosure

Item 7.01: Regulation FD Disclosure.

Mead Johnson Nutrition Company (the Company) is furnishing its
press release dated March1,2017 announcing the declaration of a
regular dividend on the Companys common stock. The press release
is included in this report as Exhibit99.1 and is incorporated
herein by reference. to general instruction B.2 to Form8-K, the
information furnished to Item7.01 shall not be deemed to be filed
for purposes of Section18 of the Exchange Act or otherwise
subject to the liabilities of that section.

Item 8.01. Other Events.

See Item 7.01. Regulation FD Disclosure above.

Item 9.01: Financial Statements and
Exhibits.

(d) Exhibits

About MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN)

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) Recent Trading Information

MEAD JOHNSON NUTRITION COMPANY (NYSE:MJN) closed its last trading session up +0.32 at 88.11 with 2,621,168 shares trading hands.